 Hepatocyte Nuclear Factor 3-alpha
"Hepatocyte Nuclear Factor 3-alpha" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A forkhead transcription factor that is an essential activator of GLUCAGON gene expression.
| Descriptor ID |
D051541
|
| MeSH Number(s) |
D12.776.260.262.750 D12.776.260.950.249.500 D12.776.660.352.750 D12.776.930.323.750 D12.776.930.977.249.500
|
| Concept/Terms |
Hepatocyte Nuclear Factor 3-alpha- Hepatocyte Nuclear Factor 3-alpha
- Hepatocyte Nuclear Factor 3 alpha
- HNF-3alpha Protein
- HNF 3alpha Protein
- Hepatocyte-Enriched Transcription Factor HNF-3A
- Hepatocyte Enriched Transcription Factor HNF 3A
- HNF-3A Transcription Factor
- HNF 3A Transcription Factor
- Transcription Factor, HNF-3A
- Forkhead Box A1 Protein
- Hepatocyte Nuclear Factor 3alpha
|
Below are MeSH descriptors whose meaning is more general than "Hepatocyte Nuclear Factor 3-alpha".
Below are MeSH descriptors whose meaning is more specific than "Hepatocyte Nuclear Factor 3-alpha".
This graph shows the total number of publications written about "Hepatocyte Nuclear Factor 3-alpha" by people in this website by year, and whether "Hepatocyte Nuclear Factor 3-alpha" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatocyte Nuclear Factor 3-alpha" by people in Profiles.
-
Cocce KJ, Jasper JS, Desautels TK, Everett L, Wardell S, Westerling T, Baldi R, Wright TM, Tavares K, Yllanes A, Bae Y, Blitzer JT, Logsdon C, Rakiec DP, Ruddy DA, Jiang T, Broadwater G, Hyslop T, Hall A, Laine M, Phung L, Greene GL, Martin LA, Pancholi S, Dowsett M, Detre S, Marks JR, Crawford GE, Brown M, Norris JD, Chang CY, McDonnell DP. The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. Cell Rep. 2019 10 22; 29(4):889-903.e10.
-
Yang YA, Zhao JC, Fong KW, Kim J, Li S, Song C, Song B, Zheng B, He C, Yu J. FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function. Nucleic Acids Res. 2016 09 30; 44(17):8153-64.
-
DeGraff DJ, Clark PE, Cates JM, Yamashita H, Robinson VL, Yu X, Smolkin ME, Chang SS, Cookson MS, Herrick MK, Shariat SF, Steinberg GD, Frierson HF, Wu XR, Theodorescu D, Matusik RJ. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation. PLoS One. 2012; 7(5):e36669.
-
He HH, Meyer CA, Shin H, Bailey ST, Wei G, Wang Q, Zhang Y, Xu K, Ni M, Lupien M, Mieczkowski P, Lieb JD, Zhao K, Brown M, Liu XS. Nucleosome dynamics define transcriptional enhancers. Nat Genet. 2010 Apr; 42(4):343-7.
-
Lee JC, Smith SB, Watada H, Lin J, Scheel D, Wang J, Mirmira RG, German MS. Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes. 2001 May; 50(5):928-36.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|